Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Nicholls

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Lancet. Psychiatry|March 9, 2026
Artificial intelligence-associated delusions and large language models: risks, mechanisms of delusion co-creation, and safeguarding strategiesHamilton Morrin, Luke Nicholls, Michael Levin, et al.
International Journal of Radiation Oncology, Biology, Physics|January 13, 2026
2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancerBinnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2024
Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 TrialBinnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Lancet. Psychiatry|March 9, 2026
Artificial intelligence-associated delusions and large language models: risks, mechanisms of delusion co-creation, and safeguarding strategiesHamilton Morrin, Luke Nicholls, Michael Levin, et al.
International Journal of Radiation Oncology, Biology, Physics|January 13, 2026
2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancerBinnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2024
Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 TrialBinnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
Pageof 2